Marlene Camacho-Rivera, ScD, MS, MPH
SUNY Downstate Health Sciences University
Community Health Sciences
What I would like to offer as a collaborator…
As a social epidemiologist, Dr. Camacho-Rivera’s research focuses on three main themes:
1. Elucidating social determinants of racial/ethnic disparities in chronic diseases such as asthma, cardiovascular diseases, and cancer
2. Exploring within-group heterogeneity in the prevention and treatment of chronic disease outcomes among racial/ethnic groups
3. Developing culturally-tailored, patient-centered interventions to improve chronic disease self-management among urban minorities
Committed to reducing urban health disparities, Dr. Camacho-Rivera’s research has been supported by the National Cancer Institute, and has been the recipient of several fellowships from the National Heart, Lung, and Blood Institute and the Association of American Medical Colleges. She has published over 20 articles and book chapters and is currently an editorial board member of PLOS ONE and Frontiers in Public Health. She is an active member of the American Association for Cancer Research, the American Public Health Association, and a fellow of the New York Academy of Medicine.
What I am looking for from a collaborator…
As a Latina first-generation college graduate, born and raised in the East New York section of Brooklyn, New York, my earliest life experiences have molded my career trajectory as a social epidemiologist and health disparities researcher.
As a Center affiliate member, my goals are to strengthen existing partnerships and develop new collaborations with faculty across Cornell to design and evaluate interventions and programs to reduce chronic disease disparities in New York City. Given my background in social epidemiology, I am most interested in examining how social and structural contexts influence how minorities navigate seeking health information and related-decision making, as well as how other chronic conditions influence their cancer-preventive behaviors, cancer outcomes, cancer survival rates, and quality of life. I would welcome opportunities to collaborate on manuscripts and funding opportunities within these areas.